Jorn C. Albring
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 05, 2026
Immune reconstitution in AML and MDS patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) with treosulfan- or TBI-based conditioning.
Journal: Bone marrow transplantation
Published: May 02, 2025
High-Dose Melphalan Followed by Busulfan and Fludarabine Conditioning Prior to Allogeneic Stem Cell Transplantation in Elderly Patients with Active Acute Myeloid Leukemia-A Retrospective Single-Center Study.
Journal: Transplantation and cellular therapy
Published: March 19, 2025
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia.
Journal: Blood
Published: September 10, 2024
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia.
Journal: British journal of haematology
Published: February 15, 2024
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients.
Journal: Bone marrow transplantation
Published: February 04, 2024
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 15, 2023
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 06, 2023
Fluorodeoxyglucose F 18 for the Assessment of Acute Intestinal Graft-versus-Host Disease and Prediction of Response to Immunosuppressive Therapy.
Journal: Transplantation and cellular therapy
Published: February 21, 2021
18F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD).
Journal: BMC cancer
Published: February 06, 2021
Last Updated: 09/26/2026